Related Experiment Video
Updated: Nov 5, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Risk Scores and Machine Learning to Identify Patients With Acute Periprosthetic Joints Infections That Will Likely
Marjan Wouthuyzen-Bakker1, Noam Shohat2,3, Javad Parvizi4
1Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Abstract:
The most preferred treatment for acute periprosthetic joint infection (PJI) is surgical debridement, antibiotics and retention of the implant (DAIR). The reported success of DAIR varies greatly and depends on a complex interplay of several host-related factors, duration of symptoms, the microorganism(s) causing the infection, its susceptibility to antibiotics and many others. Thus, there is a great clinical need to predict failure of the "classical" DAIR procedure so that this surgical option is offered to those most likely to succeed, but also to identify those patients who may benefit from more intensified antibiotic treatment regimens or new and innovative treatment strategies. In this review article, the current recommendations for DAIR will be discussed, a summary of independent risk factors for DAIR failure will be provided and the advantages and limitations of the clinical use of preoperative risk scores in early acute (post-surgical) and late acute (hematogenous) PJIs will be presented. In addition, the potential of implementing machine learning (artificial intelligence) in identifying patients who are at highest risk for failure of DAIR will be addressed. The ultimate goal is to maximally tailor and individualize treatment strategies and to avoid treatment generalization.
Insights
Predicting failure in debridement, antibiotics, and implant retention (DAIR) for joint infections is crucial. Identifying at-risk patients ensures optimal treatment, potentially using AI for personalized strategies.
Area of Science:
- Orthopedics
- Infectious Diseases
- Surgical Innovation
Background:
- Periprosthetic joint infection (PJI) is a severe complication after joint replacement surgery.
- Debridement, antibiotics, and implant retention (DAIR) is the preferred initial treatment for acute PJI.
- DAIR success rates vary significantly due to multiple patient and infection-related factors.
Purpose of the Study:
- To review current DAIR recommendations and identify independent risk factors for treatment failure.
- To evaluate the utility of preoperative risk scores for predicting DAIR outcomes in acute PJI.
- To explore the potential of machine learning in personalizing PJI treatment strategies.
Main Methods:
- Literature review of current DAIR protocols and risk factors.
- Analysis of independent risk factors associated with DAIR failure.
- Discussion of preoperative risk scores and machine learning applications for PJI management.
Main Results:
- DAIR success is influenced by host factors, infection duration, causative microorganisms, and antibiotic susceptibility.
- Independent risk factors for DAIR failure require further elucidation.
- Preoperative risk scores show potential but have limitations in clinical application.
Conclusions:
- Accurate prediction of DAIR failure is essential for patient selection and treatment optimization.
- Machine learning offers promising avenues for identifying high-risk patients and tailoring interventions.
- Individualized treatment strategies are paramount to improve outcomes in acute PJI.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management

